Product Candidates |
Indication |
Development Stage |
Status |
Development Programs |
|
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
VK2809 (TRb Agonist) |
NASH |
|
Phase 2b VOYAGE trial ongoing |
VK0214 (TRb Agonist) |
X-ALD |
|
Phase 1b |
VK2735 (Dual GLP-1/GIP agonist) |
Metabolic disorders |
|
Phase 1 ongoing |
Other Programs |
|
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
VK5211 (SARM) |
Hip fracture, muscle wasting |
|
Phase 2 completed |
VK0612 (FBPase inhibitor) |
Type 2 Diabetes |
|
Phase 2a completed |
VK1430 (DGAT-1 inhibitor) |
Hypertriglyceridemia, NASH |
|
Preclinical |